Who Paid My Doc
Elitek
Biological Oncology
NDC 0024-5151-75
General payments
$968,942
Research payments
$55,291
Through program year 2025, $968,942 in general payments and $55,291 in research payments were reported against Elitek (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $43,154 | 4 |
| 2024 | General | $1,582 | 22 |
| 2024 | Research | $12,137 | 1 |
| 2023 | General | $169,896 | 1,629 |
| 2022 | General | $346,067 | 4,691 |
| 2021 | General | $267,326 | 3,476 |
| 2020 | General | $183,867 | 2,060 |
| 2019 | General | $203 | 2 |
Breakdown
The top 5 of 22 recipients; each share is of general payments naming this product in 2024.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 12 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
11,880 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.